Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00489008 · ClinicalTrials.gov registry record · Phase 2
SRS Study in Patients With Non-Small Cell Lung Cancer
A Phase 2 study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 141
- Enrollment target
NCT00489008: Completed Phase 2 study, sponsored by M.D. Anderson Cancer Center.
NCT00489008 is a Phase 2 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 141 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00489008, a Phase 2 study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 141 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to learn if stereotactic body radiotherapy (SBRT) can help to control NSCLC. The safety of SBRT will also be studied. Objectives: To assess therapeutic efficacy and toxicities of stereotactic body radiotherapy (SBRT) for patients with medically inoperable stage I (T1-2, N0,M0), selective stage II (chest wall T3, N0M0) or isolated peripheral lung recurrent non-small cell lung cancer (NSCLC). Primary goal: Improve 2 years progression free survival at the treated primary tumor site. Secondary goals: 1. Improve disease free survival, disease specific survival and overall survival at 2 years. 2. Decrease grade 3 and above acute and/or chronic toxicities. 3. Collect blood for future biomarkers study
Interventions
- PROCEDURE Stereotactic Body Radiation Therapy (SBRT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 141 participants |
| Start Date | 2005-11-21 |
| Est. Completion | 2017-06-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00489008
The ClinicalTrials.gov registry entry for NCT00489008 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 141 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Stereotactic Body Radiation Therapy (SBRT) is the first listed.
NCT00489008 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00489008 about?
NCT00489008 is a clinical study titled "SRS Study in Patients With Non-Small Cell Lung Cancer". The goal of this clinical research study is to learn if stereotactic body radiotherapy (SBRT) can help to control NSCLC. The safety of SBRT will also be studied. Objectives: To assess therapeutic efficacy and toxicities of stereotactic body radiotherapy (SBRT) for patients with medically inoperabl...
What is the current status of trial NCT00489008?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 141 participants. The study started on 2005-11-21. Estimated completion is 2017-06-02.
What interventions are being tested in trial NCT00489008?
The interventions under investigation include: Stereotactic Body Radiation Therapy (SBRT) (PROCEDURE).
Who is sponsoring clinical trial NCT00489008?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.